Cargando…

The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2

OBJECTIVE: In this study, we mainly explored the mechanism and target of the anti-inflammatory effects of Aureusidin (Aur) in acute liver injury. METHODS: Lipopolysaccharide (LPS) was used to induce inflammatory injury in Kupffer cells (KCs) in vitro. After Aur treatment with gradient concentration,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Han, Chenyang, Sheng, Yongjia, Wang, Jin, Zhou, Xiaohong, Li, Wenyan, Guo, Li, Ruan, Shuiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655772/
https://www.ncbi.nlm.nih.gov/pubmed/33192512
http://dx.doi.org/10.3389/fphar.2020.570776
_version_ 1783608237619150848
author Yang, Yi
Han, Chenyang
Sheng, Yongjia
Wang, Jin
Zhou, Xiaohong
Li, Wenyan
Guo, Li
Ruan, Shuiliang
author_facet Yang, Yi
Han, Chenyang
Sheng, Yongjia
Wang, Jin
Zhou, Xiaohong
Li, Wenyan
Guo, Li
Ruan, Shuiliang
author_sort Yang, Yi
collection PubMed
description OBJECTIVE: In this study, we mainly explored the mechanism and target of the anti-inflammatory effects of Aureusidin (Aur) in acute liver injury. METHODS: Lipopolysaccharide (LPS) was used to induce inflammatory injury in Kupffer cells (KCs) in vitro. After Aur treatment with gradient concentration, flow cytometry, propidium iodide (PI) staining, and Hoechst 33342 staining were used to detect the apoptotic level of KCs, and an enzyme-linked immunosorbent assay (ELISA) was used to detect the expression levels of inflammatory factors, including Interleukin-1β (IL-1β), Interleukin-18 (IL-18), and tumor necrosis factor alpha (TNF-α). Western blot was used to detect the expression of toll-like receptor 4 (TLR4), myeloid differentiation protein-2 (MD2), MyD88, and p-P65. Aur was labeled with biotin, followed by a pull-down assay to detect its binding with MD2. Moreover, D-GalN/LPS was used to induce acute liver injury in mice in vitro, followed by Aur treatment by gavage. H&E staining was used to detect the pathological changes of liver tissue, an IF assay was used to detect the expression of MD2, Western blot was used to detect the expression of relevant proteins. RESULTS: Aur pretreatment could significantly inhibit LPS-induced KC injury, downregulate the apoptotic level, inhibit the expression of inflammatory factors, decrease the level of MDA, and downregulate the expression of MD2 in cells. Aur could inhibit the activation level of TLR4/MD2-NF-κB in a dose-dependent pattern, a high dose of Aur had a superior effect compared to low-dose Aur. In the case of MD2 deletion, the effects of Aur were suppressed. Additionally, pull-down and co-immunoprecipitation assays show that Aur can bind with the MD2 protein to inhibit the activation of TLR4/MD2-NF-κB. Results of mice experiments also showed that Aur could relieve liver injury, decrease the levels of ALT and AST, and simultaneously downregulate the levels of inflammatory factors in tissues and peripheral blood. CONCLUSION: We found that Aur exerted an anti-inflammatory effect by directly targeting the MD2 protein, further inhibiting the expression of TLR4/MD2-NF-κB, thereby relieving acute liver injury. Therefore, Aur might be a potential inhibitor for MD2.
format Online
Article
Text
id pubmed-7655772
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76557722020-11-13 The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2 Yang, Yi Han, Chenyang Sheng, Yongjia Wang, Jin Zhou, Xiaohong Li, Wenyan Guo, Li Ruan, Shuiliang Front Pharmacol Pharmacology OBJECTIVE: In this study, we mainly explored the mechanism and target of the anti-inflammatory effects of Aureusidin (Aur) in acute liver injury. METHODS: Lipopolysaccharide (LPS) was used to induce inflammatory injury in Kupffer cells (KCs) in vitro. After Aur treatment with gradient concentration, flow cytometry, propidium iodide (PI) staining, and Hoechst 33342 staining were used to detect the apoptotic level of KCs, and an enzyme-linked immunosorbent assay (ELISA) was used to detect the expression levels of inflammatory factors, including Interleukin-1β (IL-1β), Interleukin-18 (IL-18), and tumor necrosis factor alpha (TNF-α). Western blot was used to detect the expression of toll-like receptor 4 (TLR4), myeloid differentiation protein-2 (MD2), MyD88, and p-P65. Aur was labeled with biotin, followed by a pull-down assay to detect its binding with MD2. Moreover, D-GalN/LPS was used to induce acute liver injury in mice in vitro, followed by Aur treatment by gavage. H&E staining was used to detect the pathological changes of liver tissue, an IF assay was used to detect the expression of MD2, Western blot was used to detect the expression of relevant proteins. RESULTS: Aur pretreatment could significantly inhibit LPS-induced KC injury, downregulate the apoptotic level, inhibit the expression of inflammatory factors, decrease the level of MDA, and downregulate the expression of MD2 in cells. Aur could inhibit the activation level of TLR4/MD2-NF-κB in a dose-dependent pattern, a high dose of Aur had a superior effect compared to low-dose Aur. In the case of MD2 deletion, the effects of Aur were suppressed. Additionally, pull-down and co-immunoprecipitation assays show that Aur can bind with the MD2 protein to inhibit the activation of TLR4/MD2-NF-κB. Results of mice experiments also showed that Aur could relieve liver injury, decrease the levels of ALT and AST, and simultaneously downregulate the levels of inflammatory factors in tissues and peripheral blood. CONCLUSION: We found that Aur exerted an anti-inflammatory effect by directly targeting the MD2 protein, further inhibiting the expression of TLR4/MD2-NF-κB, thereby relieving acute liver injury. Therefore, Aur might be a potential inhibitor for MD2. Frontiers Media S.A. 2020-10-28 /pmc/articles/PMC7655772/ /pubmed/33192512 http://dx.doi.org/10.3389/fphar.2020.570776 Text en Copyright © 2020 Yang, Han, Sheng, Wang, Zhou, Li, Guo and Ruan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yang, Yi
Han, Chenyang
Sheng, Yongjia
Wang, Jin
Zhou, Xiaohong
Li, Wenyan
Guo, Li
Ruan, Shuiliang
The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
title The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
title_full The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
title_fullStr The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
title_full_unstemmed The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
title_short The Mechanism of Aureusidin in Suppressing Inflammatory Response in Acute Liver Injury by Regulating MD2
title_sort mechanism of aureusidin in suppressing inflammatory response in acute liver injury by regulating md2
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655772/
https://www.ncbi.nlm.nih.gov/pubmed/33192512
http://dx.doi.org/10.3389/fphar.2020.570776
work_keys_str_mv AT yangyi themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT hanchenyang themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT shengyongjia themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT wangjin themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT zhouxiaohong themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT liwenyan themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT guoli themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT ruanshuiliang themechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT yangyi mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT hanchenyang mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT shengyongjia mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT wangjin mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT zhouxiaohong mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT liwenyan mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT guoli mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2
AT ruanshuiliang mechanismofaureusidininsuppressinginflammatoryresponseinacuteliverinjurybyregulatingmd2